Načítá se...
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2018-05-01
|
| Edice: | Experimental Hematology & Oncology |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|